FDA Enforcement Class II Terminated

Allura Xper Product Usage: Vascular,cardiovascular and neurovascular imaging applications,including diagnostic, interventional and minimally invasive procedures. Cardiac imaging applications including diagnostics, interventional and minimally invasive procedures (such as PTCA,stent placing,atherectomies), pacemaker implantat ions, and electrophysiology (EP). Non-vascular interventions such as drainages,biopsies and vertebroplasties procedures.

Recall: Z-2498-2018 · Reported August 1, 2018

Enforcement

Recall Number
Z-2498-2018
Event ID
80402
Classification
Class II
Status
Terminated
Product Type
Devices
Firm
Philips Healthcare
Voluntary / Mandated
FDA Mandated
Initial Notification
Letter
Report Date
August 1, 2018
Initiation Date
June 11, 2018
Classification Date
July 24, 2018
Termination Date
July 3, 2024
Address
3000 Minuteman Rd, N/A, Andover, MA, 01810-1032, United States

Description

Allura Xper Product Usage: Vascular,cardiovascular and neurovascular imaging applications,including diagnostic, interventional and minimally invasive procedures. Cardiac imaging applications including diagnostics, interventional and minimally invasive procedures (such as PTCA,stent placing,atherectomies), pacemaker implantat ions, and electrophysiology (EP). Non-vascular interventions such as drainages,biopsies and vertebroplasties procedures.

Reason

The first time an operator selects a new procedure type during a single examination,the shutter position resets to the open position for the new procedure type. If the shutters had previously been changed during the examination, that setting is not retained after the first time the procedure type is changed during a single examination.

Code Info

Allura 8.1.25 Allura 8.1.25.1 Allura 8.1.25.5 Allura 8.2.25 Allura 8.2.25.5 Allura 8.2.27

Distribution

US Nationwide Distribution

Quantity

459 affected systems